## Abstract Detailed characterization of the cancer genome in a large number of primary human glioblastomas has identified recurrent alterations that result in deregulation of signal transduction pathways and are βdruggableβ with a growing number of small molecule pharmaceuticals. While many of the
β¦ LIBER β¦
Issues and Challenges for Antiangiogenic Therapies
β Scribed by Kathy D. Miller
- Book ID
- 110394534
- Publisher
- Springer US
- Year
- 2002
- Tongue
- English
- Weight
- 136 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Signal transduction inhibitors and antia
β
Ingo K. Mellinghoff; Andrew B. Lassman; Patrick Y. Wen
π
Article
π
2011
π
John Wiley and Sons
π
English
β 284 KB
π 1 views
Angiogenesis and Antiangiogenic Therapy
β
George W. Sledge Jr; Kathy D. Miller
π
Article
π
2002
π
Elsevier Science
π
English
β 233 KB
and poor tumor differentiation. In addition, Linderholm's data suggest that VEGF production is associated with an increased risk of brain and visceral metastasis, a finding confirmed by Foekens et al. 14 Although perhaps best studied in breast cancer, the number of cancers in which VEGF tissue expre
Angiogenesis and antiangiogenic therapy
β
Shingo Takano; Hiroshi Kamiyama; Koji Tsuboi; Akira Matsumura
π
Article
π
2004
π
Springer Japan
π
English
β 404 KB
Biological therapies: concepts and chall
β
Markus MΓΌller
π
Article
π
2006
π
Springer Vienna
π
English
β 84 KB
Antiangiogenic therapy and surgical prac
β
A. R. John; S. R. Bramhall; M. C. Eggo
π
Article
π
2008
π
John Wiley and Sons
π
English
β 176 KB
Antiangiogenic therapy: Not just for can
β
Vijay H. Shah; Jordi Bruix
π
Article
π
2009
π
John Wiley and Sons
π
English
β 166 KB